WebbKu C, Wuputra K, Kato K et al. Deletion of Jdp2 enhances Slc7a11 expression in Atoh-1 positive cerebellum granule cell progenitors in vivo Stem Cell Research & Therapy 2024-12-01 [PMID: 34187574] Sharbeen G, McCarroll J, Akerman A et al. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 … WebbCancer-associated fibroblasts (CAF) are major contributors to pancreatic ductal adenocarcinoma (PDAC) progression through protumor signaling and the generation of …
SLC7A11 / XCT - LSBio
Webb12 juli 2024 · SLC7A11 is a cystine transporter that has been identified as a potential therapeutic target in PDAC cells. However, no prior study has evaluated the role of SLC7A11 in PDAC tumour stroma and its prognostic significance. Webb22 juni 2024 · The SLC7A11 transporter is involved in different mechanisms of multistage reactions during tumourigenesis in different types of cancer cells. Previous studies … how many seats are in kyle field
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma
Webb20 apr. 2024 · Recent research suggests that cancer therapies, such as immunotherapy and radiotherapy, can induce ferroptosis partly through modulating SLC7A11 expression (Lang et al., 2024; Lei et al., 2024); knockout or inhibition of SLC7A11 has a significant inhibitory effect on lung cancer and pancreatic cancer cells (Ji et al., 2024; Sharbeen et … WebbLowy Cancer Research Centre; George Sharbeen; ... CAF inhibition is thus an ideal component of any therapeutic approach for PDAC. SLC7A11 is a cystine transporter that … WebbGeorge Sharbeen (0000-0002-6373-1930) George Sharbeen Activities Works (22) Sort Aerosol delivery of star polymer-siRNA nanoparticles as a therapeutic strategy to inhibit … how did france form